Clinical Trials Directory

Trials / Unknown

UnknownNCT02992665

Can Calcium Ionophore Application Enhance the ICSI Outcomes in Severe Male Factor Infertility?

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the impact of the use of calcium ionophore on the ICSI outcomes in couples with severe male factor infertility. Investigators conduct a randomized controlled trial on the sibling oocyte to justify the use of calcium ionophore in these cases.

Detailed description

Elevation of calcium levels inside the oocyte is one of the most initial steps which takes place during normal fertilization (1). The interaction between the sperm and oocytes surface protein receptors may be the triggering event for oocyte activation during the process of fertilization (2). It is suggested that the process of intracellular Calcium elevation is triggered by binding of the sperm to the oocyte oolemma and hence the fertilization starts (3). Severe male factor couples might have compromised fertilization and pregnancy outcomes (4). A prospective multicenter non-randomized study indicated that calcium ionophore could improve the fertilization as well as the clinical pregnancy rates in these patients (5). On the other hand, a randomized controlled trial did not find any significance for the use of calcium ionophore in the couples with poor ovarian reserve with regards the fertilization and clinical pregnancy rates (6). The purpose of this study is to determine the impact of the use of calcium ionophore on the ICSI outcomes in couples with severe male factor infertility. Investigators conduct a randomized controlled trial on the sibling oocyte to justify the use of calcium ionophore in these cases.

Conditions

Interventions

TypeNameDescription
DRUGCa Ionophore A23187Sibling oocytes are to be randomized to artificially activated using Calcium ionophore in cases with severely compromized semen parameters
OTHERPlaceboPlacebo is used to control Ca ionophore group

Timeline

Start date
2016-12-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-12-14
Last updated
2016-12-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02992665. Inclusion in this directory is not an endorsement.